0000899243-23-000630.txt : 20230104 0000899243-23-000630.hdr.sgml : 20230104 20230104163515 ACCESSION NUMBER: 0000899243-23-000630 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiniara Ellen CENTRAL INDEX KEY: 0001398764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 23507085 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD, SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 0 0001815442 Kymera Therapeutics, Inc. KYMR 0001398764 Chiniara Ellen C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS BLVD. SUITE 230 WATERTOWN MA 02472 0 1 0 0 Chief Legal Officer Common Stock 2023-01-03 4 A 0 37500 0.00 A 37500 D Stock Option (Right to Buy) 24.84 2023-01-03 4 A 0 225000 0.00 A 2033-01-02 Common Stock 225000 225000 D Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following January 3, 2023, subject to the reporting person's continued employment through each vesting date. 25% of the shares underlying this stock option shall vest on January 3, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date. /s/ Bruce Jacobs, as Attorney-in-Fact 2023-01-04